{
    "root": "e972f271-885a-456e-b05d-fe9a3693443f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": "Glipizide",
    "value": "20250304",
    "ingredients": [
        {
            "name": "GLIPIZIDE",
            "code": "X7WDT95N5C",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5384"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE OXIDE 200000",
            "code": "11628IH70O",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "POLYETHYLENE OXIDE 7000000",
            "code": "G3MS6M810Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "CELLULOSE ACETATE",
            "code": "3J2P07GVB6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145232"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        }
    ],
    "indications": {
        "text": "glipizide extended-release tablets indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
        "doid_entities": [
            {
                "text": "type 2 diabetes mellitus (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended starting dose 5 mg daily . dose adjustment made based patient \u2019 glycemic control . maximum recommended dose 20 mg daily ( 2.1 ) . administer breakfast first meal day ( 2.1 ) . combination therapy blood-glucose-lowering agents , initiate agent lowest recommended dose , observe patients hypoglycemia ( 2.2 ) .",
        "doid_entities": [
            {
                "text": "hypoglycemia (DOID:9993)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9993"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "glipizide extended-release tablets supplied provide 2.5 mg , 5 mg , 10 mg round , biconvex tablets imprinted black ink follows : table 2 : glipizide extended-release tablet presentations tablet strength tablet color/ shape tablet markings package size ndc code 2.5 mg blue round biconvex imprinted \u201c p \u201d one side . 2.5 bottles 30 ndc 64980-279-03 5 mg white round biconvex imprinted \u201c p \u201d one side . 5 bottles 100 ndc 64980-280-01 imprinted \u201c p \u201d one side . 5 bottles 500 ndc 64980-280-05 imprinted \u201c p \u201d one side . 5 bottles 1000 ndc 64980-280-10 10 mg white round biconvex imprinted \u201c p \u201d one side . 10 bottles 100 ndc 64980-281-01 imprinted \u201c p \u201d one side . 10 bottles 500 ndc 64980-281-05 imprinted \u201c p \u201d one side . 10 bottles 1000 ndc 64980-281-10 recommended storage : tablets protected moisture humidity . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00ba f ) ; [ usp controlled room temperature ] .",
    "adverseReactions": "glipizide contraindicated patients : known hypersensitivity glipizide product \u2019 ingredients . hypersensitivity sulfonamide derivatives .",
    "indications_original": "Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications_original": "Recommended starting dose is 5 mg once daily. Dose adjustment can be made based on the patient\u2019s glycemic control. Maximum recommended dose is 20 mg once daily ( 2.1 ). Administer with breakfast or the first meal of the day ( 2.1 ). For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe patients for hypoglycemia ( 2.2 ).",
    "warningsAndPrecautions_original": "Glipizide extended-release tablets are supplied to provide\u00a02.5 mg, 5 mg, and 10 mg round, biconvex tablets and imprinted with black ink as follows:\n                  \n                  \n                     \n                         \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Table 2: Glipizide extended-release tablet Presentations\n                  \n                  \n                  \n                     \n                        \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \n                              \n                              \n                              Tablet Strength\n                              \n                           \n                           \n                              \n                              \n                              Tablet Color/ Shape\n                              \n                           \n                           \n                              \n                              \n                              Tablet Markings\n                              \n                           \n                           \n                              \n                              \n                              Package Size\n                              \n                           \n                           \n                              \n                              \n                              NDC Code\n                              \n                           \n                        \n                        \n                           \n                              \n                              2.5 mg\n                           \n                           \n                              \n                              Blue Round Biconvex\n                           \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0 2.5\n                           \n                           \n                              \n                              Bottles of 30\n                           \n                           \n                              \n                              NDC 64980-279-03\n                           \n                        \n                        \n                           \n                              \n                              5 mg\n                           \n                           \n                              \n                              White Round Biconvex\n                           \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 5\n                           \n                           \n                              \n                              Bottles of 100\n                           \n                           \n                              \n                              NDC 64980-280-01\n                           \n                        \n                        \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 5\n                           \n                           \n                              \n                              Bottles of 500\n                           \n                           \n                              \n                              NDC 64980-280-05\n                           \n                        \n                        \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 5\n                           \n                           \n                              \n                              Bottles of 1000\n                           \n                           \n                              \n                              NDC 64980-280-10\n                           \n                        \n                        \n                           \n                              \n                              10 mg\n                           \n                           \n                              \n                              White Round Biconvex\n                           \n                           \n                              \n                              imprinted with \u201cP \u201d on one side.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 10\n                           \n                           \n                              \n                              Bottles of 100\n                           \n                           \n                              \n                              NDC 64980-281-01\n                           \n                        \n                        \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 10\n                           \n                           \n                              \n                              Bottles of 500\n                           \n                           \n                              \n                              NDC 64980-281-05\n                           \n                        \n                        \n                           \n                              \n                              imprinted with \u201cP \u201d on one side. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a010\n                           \n                           \n                              \n                              Bottles of 1000\n                           \n                           \n                              \n                              NDC 64980-281-10\n                           \n                        \n                     \n                  \n                  \n                  \n                     Recommended Storage: The tablets should be protected from moisture and humidity. Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00ba F); [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Glipizide is contraindicated in patients with:\n                  \n                     Known hypersensitivity to glipizide or any of the product\u2019s ingredients.\n                     Hypersensitivity to sulfonamide derivatives.",
    "drug": [
        {
            "name": "Glipizide",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5384"
        }
    ]
}